Clinical Trial Update: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

View source ↗

Summary

Extension study update for the European sickle cell disease cohort evaluating hydroxyurea (ESCORT-HU Extension); current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Theravia | Conditions: Sickle Cell Disease | Status: ACTIVE_NOT_RECRUITING